Tuberculosis

Tuberculosis (TB) continues to occur in New Zealand. Approximately 300 cases of TB are diagnosed each year.

TB control in the 21st century faces many challenges at the global, regional and national level. The problems of poverty, adherence to treatment and stigma still prevail, while increasing drug resistance and HIV co-infection demand new approaches.

Due to a number of manufacturing issues which have affected global vaccine supplies, BCG vaccine was not available in New Zealand between 2016 and mid 2018. The vaccine is now available from public health community BCG vaccination clinics and in-hospital vaccinations. For more information see Resumption of BCG vaccination following vaccine shortage.

For more information on TB, including symptoms and immunisation information, go to the YourHealth consumer section.

Publications

2018

Tuberculosis Case Management for People In Correctional Facilities
The publication provides guidance for the staff of corrections facilities, public health services and clinical TB services in New Zealand, to enable them to carry out tasks relating to the case management of people with active TB disease or with latent TB infection in corrections facilities.

2012

Communicable Disease Control Manual
The Communicable Disease Control Manual seeks to inform and assist those at the frontline of public health action, namely the medical officers of health, health protection officers and staff at public health units. The manual describes the standard practice that public health services would normally follow in regard to the prevention and control of notifiable diseases such as tuberculosis.

2010

Guidelines for Tuberculosis Control in New Zealand 2010
Please note: This publication is currently under review.

2007

Review of Neonatal BCG Immunisation Services in New Zealand
This review evaluates the neonatal BCG immunisation service in New Zealand.

2001

Directly Observed Therapy (DOT) for Tuberculosis
Detection and cure remains the cornerstone of TB control. Directly observed therapy (DOT) ensures adherence. The Tuberculosis Working Group of the Ministry of Health strongly supports the use of DOT and urges all Medical Officers of Health to work with local medical practitioners to ensure that DOT is offered to all patients who are likely to benefit from it.

In this section

Back to top